PDK4 Inhibition Ameliorates Melatonin Therapy by Modulating Cerebral Metabolism and Remyelination in an EAE Demyelinating Mouse Model of Multiple Sclerosis

ClinicalTrials.gov NCT03498131. Keywords: PDC; PDK4; diisopropylamine dichloroacetate; experimental autoimmune encephalomyelitis (EAE); fatty acids; melatonin; multiple scleorsis (MS); neuroinflammation.